Search research articles
Contact Us
Filters
Showing results (11-20 of 46) with videos related to
Page
of 5
Sort By:
International Journal of Surgery (London, England)
|
March 18, 2024
Assessment of treatment outcomes: cytoreductive surgery compared to radiotherapy in oligometastatic prostate cancer - an in-depth quantitative evaluation and retrospective cohort analysis
Bisheng Cheng, Haixia He, Bingliang Chen, et al.
Optics Letters
|
October 15, 2024
C3SI-compact complementary compressed spectral imaging
Bingliang Chen, Qiuyu Yue, Xinyu Liu, et al.
Antibody Therapeutics
|
April 30, 2021
A novel antibody targeting TIM-3 resulting in receptor internalization for cancer immunotherapy
Zhihui Kuang, Li Li, Pan Zhang, et al.
Frontiers in Genetics
|
October 6, 2022
LMO3 downregulation in PCa: A prospective biomarker associated with immune infiltration
Wenchao Xu, Taotao Sun, Jiaxin Wang, et al.
Cancer Cell International
|
November 11, 2022
Integrated analysis to identify the AC005154.6/hsa-miR-29c-3p/CCNL2 axis as a novel prognostic biomarker associated with immune infiltration in prostate cancer
Qinyu Li, Bingliang Chen, Guoda Song, et al.
The Journal of Biological Chemistry
|
March 26, 2002
Activation of vascular endothelial growth factor A transcription in tumorigenic glioblastoma cell lines by an enhancer with cell type-specific DNase I accessibility
Yuxin Liang, Xiao-Yong Li, Edward J Rebar, et al.
Frontiers in Oncology
|
October 31, 2022
A predictive signature based on enhancer RNA associates with immune infiltration and aids treatment decision in clear cell renal cell carcinoma
Qinyu Li, Xueyan Xiao, Bingliang Chen, et al.
Optics Express
|
December 19, 2025
Edge-aware adaptive hyperspectral acquisition via synergistic dual-camera architecture
Bingliang Chen, Changwei Zhang, Yang Zhang, et al.
Molecular Cancer Therapeutics
|
October 1, 2020
A Novel Bispecific Antibody with PD-L1-assisted OX40 Activation for Cancer Treatment
Zhihui Kuang, Pu Pu, Min Wu, et al.
Heliyon
|
January 16, 2024
STX4 as a potential biomarker for predicting prognosis and guiding clinical treatment decisions in clear cell renal cell carcinoma
Kai Zeng, Qinyu Li, Xi Wang, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 46) with videos related to
Sort By:
Page
of 5
International Journal of Surgery (London, England)
|
March 18, 2024
Assessment of treatment outcomes: cytoreductive surgery compared to radiotherapy in oligometastatic prostate cancer - an in-depth quantitative evaluation and retrospective cohort analysis
Bisheng Cheng, Haixia He, Bingliang Chen, et al.
Optics Letters
|
October 15, 2024
C3SI-compact complementary compressed spectral imaging
Bingliang Chen, Qiuyu Yue, Xinyu Liu, et al.
Antibody Therapeutics
|
April 30, 2021
A novel antibody targeting TIM-3 resulting in receptor internalization for cancer immunotherapy
Zhihui Kuang, Li Li, Pan Zhang, et al.
Frontiers in Genetics
|
October 6, 2022
LMO3 downregulation in PCa: A prospective biomarker associated with immune infiltration
Wenchao Xu, Taotao Sun, Jiaxin Wang, et al.
Cancer Cell International
|
November 11, 2022
Integrated analysis to identify the AC005154.6/hsa-miR-29c-3p/CCNL2 axis as a novel prognostic biomarker associated with immune infiltration in prostate cancer
Qinyu Li, Bingliang Chen, Guoda Song, et al.
The Journal of Biological Chemistry
|
March 26, 2002
Activation of vascular endothelial growth factor A transcription in tumorigenic glioblastoma cell lines by an enhancer with cell type-specific DNase I accessibility
Yuxin Liang, Xiao-Yong Li, Edward J Rebar, et al.
Frontiers in Oncology
|
October 31, 2022
A predictive signature based on enhancer RNA associates with immune infiltration and aids treatment decision in clear cell renal cell carcinoma
Qinyu Li, Xueyan Xiao, Bingliang Chen, et al.
Optics Express
|
December 19, 2025
Edge-aware adaptive hyperspectral acquisition via synergistic dual-camera architecture
Bingliang Chen, Changwei Zhang, Yang Zhang, et al.
Molecular Cancer Therapeutics
|
October 1, 2020
A Novel Bispecific Antibody with PD-L1-assisted OX40 Activation for Cancer Treatment
Zhihui Kuang, Pu Pu, Min Wu, et al.
Heliyon
|
January 16, 2024
STX4 as a potential biomarker for predicting prognosis and guiding clinical treatment decisions in clear cell renal cell carcinoma
Kai Zeng, Qinyu Li, Xi Wang, et al.
Page
of 5